Skip to main content

HCC 20: Lung and Other Severe Cancers

HCC 20, Lung and Other Severe Cancers, is one of the 115 payment categories in the CMS-HCC V28 model. 233 ICD-10-CM codes map to it in the payment year 2027 mapping, and a documented diagnosis in the category adds a relative factor of 1.136 to the risk score of a community, non-dual, aged beneficiary (0.978 disabled, 0.672 institutional). It is overridden when a more severe category in its hierarchy is present (HCC 17, HCC 18, HCC 19) and it in turn overrides HCC 21, HCC 22, HCC 23.

QuickIntell editorial content · Legacy registry date · Review not verified

Data effective
Data currency: ICD-10-CM to HCC mapping PY2027 initial (effective dates of service 2026, payment year 2027); CMS-HCC V28 model software V2826.115.T2 (effective payment year 2027). Next CMS release: PY2027 midyear final mapping (spring 2027) and PY2028 proposed model (February 2027).
Mapped ICD-10-CM codes
233
Factor, community non-dual aged
1.136
Factor, institutional
0.672
Hierarchy
Overridden by HCC 17, HCC 18, HCC 19
Disease group
Neoplasm

Relative factors by segment

Each segment is a separate regression; the factor is added to the beneficiary's demographic factors and other categories, then normalized and reduced by the coding intensity adjustment before it meets the plan's base rate. A factor of 1.000 equals the expected cost of an average beneficiary.

CMS-HCC V28 relative factors for HCC 20 by model segment
SegmentModel codeRelative factor
Community, non-dual, agedCNA_HCC201.136
Community, non-dual, disabledCND_HCC200.978
Community, full-benefit dual, agedCFA_HCC201.166
Community, full-benefit dual, disabledCFD_HCC201.173
Community, partial-benefit dual, agedCPA_HCC201.214
Community, partial-benefit dual, disabledCPD_HCC201.067
Long-term institutionalINS_HCC200.672

Hierarchy

Hierarchical condition categories pay only the most severe manifestation of a disease. When HCC 17 (Cancer Metastatic to Lung, Liver, Brain, and Other Organs; Acute Myeloid Leukemia Except Promyelocytic) or HCC 18 (Cancer Metastatic to Bone, Other and Unspecified Metastatic Cancer; Acute Leukemia Except Myeloid) or HCC 19 (Myelodysplastic Syndromes, Multiple Myeloma, and Other Cancers) is also documented for the same beneficiary, HCC 20 is dropped from the score. When HCC 20 is present it drops HCC 21 (Lymphoma and Other Cancers), HCC 22 (Bladder, Colorectal, and Other Cancers), HCC 23 (Prostate, Breast, and Other Cancers and Tumors), so documenting the less severe condition alongside it adds nothing to payment but still matters for the clinical record.

ICD-10-CM codes that map to HCC 20

233 codes map to this category in the PY2027 initial mapping, concentrated in the C84 (55), C83 (45), C34 (16), C72 (14), C93 (12), C71 (10) code families. Descriptions are the CMS mapping descriptions for the FY2026 code set; a code that is deleted or split in the October code update stays valid for dates of service before the change.

ICD-10-CM codes mapped to HCC 20 in the CMS PY2027 initial mapping
ICD-10-CMDescription
C153Malignant neoplasm of upper third of esophagus
C154Malignant neoplasm of middle third of esophagus
C155Malignant neoplasm of lower third of esophagus
C158Malignant neoplasm of overlapping sites of esophagus
C159Malignant neoplasm of esophagus, unspecified
C160Malignant neoplasm of cardia
C161Malignant neoplasm of fundus of stomach
C162Malignant neoplasm of body of stomach
C163Malignant neoplasm of pyloric antrum
C164Malignant neoplasm of pylorus
C165Malignant neoplasm of lesser curvature of stomach, unspecified
C166Malignant neoplasm of greater curvature of stomach, unspecified
C168Malignant neoplasm of overlapping sites of stomach
C169Malignant neoplasm of stomach, unspecified
C170Malignant neoplasm of duodenum
C171Malignant neoplasm of jejunum
C172Malignant neoplasm of ileum
C173Meckel's diverticulum, malignant
C178Malignant neoplasm of overlapping sites of small intestine
C179Malignant neoplasm of small intestine, unspecified
C220Liver cell carcinoma
C221Intrahepatic bile duct carcinoma
C222Hepatoblastoma
C223Angiosarcoma of liver
C224Other sarcomas of liver
C227Other specified carcinomas of liver
C228Malignant neoplasm of liver, primary, unspecified as to type
C229Malignant neoplasm of liver, not specified as primary or secondary
C23Malignant neoplasm of gallbladder
C240Malignant neoplasm of extrahepatic bile duct
C241Malignant neoplasm of ampulla of Vater
C248Malignant neoplasm of overlapping sites of biliary tract
C249Malignant neoplasm of biliary tract, unspecified
C250Malignant neoplasm of head of pancreas
C251Malignant neoplasm of body of pancreas
C252Malignant neoplasm of tail of pancreas
C253Malignant neoplasm of pancreatic duct
C254Malignant neoplasm of endocrine pancreas
C257Malignant neoplasm of other parts of pancreas
C258Malignant neoplasm of overlapping sites of pancreas
C259Malignant neoplasm of pancreas, unspecified
C33Malignant neoplasm of trachea
C3400Malignant neoplasm of unspecified main bronchus
C3401Malignant neoplasm of right main bronchus
C3402Malignant neoplasm of left main bronchus
C3410Malignant neoplasm of upper lobe, unspecified bronchus or lung
C3411Malignant neoplasm of upper lobe, right bronchus or lung
C3412Malignant neoplasm of upper lobe, left bronchus or lung
C342Malignant neoplasm of middle lobe, bronchus or lung
C3430Malignant neoplasm of lower lobe, unspecified bronchus or lung
C3431Malignant neoplasm of lower lobe, right bronchus or lung
C3432Malignant neoplasm of lower lobe, left bronchus or lung
C3480Malignant neoplasm of overlapping sites of unspecified bronchus and lung
C3481Malignant neoplasm of overlapping sites of right bronchus and lung
C3482Malignant neoplasm of overlapping sites of left bronchus and lung
C3490Malignant neoplasm of unspecified part of unspecified bronchus or lung
C3491Malignant neoplasm of unspecified part of right bronchus or lung
C3492Malignant neoplasm of unspecified part of left bronchus or lung
C380Malignant neoplasm of heart
C384Malignant neoplasm of pleura
C480Malignant neoplasm of retroperitoneum
C481Malignant neoplasm of specified parts of peritoneum
C482Malignant neoplasm of peritoneum, unspecified
C488Malignant neoplasm of overlapping sites of retroperitoneum and peritoneum
C700Malignant neoplasm of cerebral meninges
C701Malignant neoplasm of spinal meninges
C709Malignant neoplasm of meninges, unspecified
C710Malignant neoplasm of cerebrum, except lobes and ventricles
C711Malignant neoplasm of frontal lobe
C712Malignant neoplasm of temporal lobe
C713Malignant neoplasm of parietal lobe
C714Malignant neoplasm of occipital lobe
C715Malignant neoplasm of cerebral ventricle
C716Malignant neoplasm of cerebellum
C717Malignant neoplasm of brain stem
C718Malignant neoplasm of overlapping sites of brain
C719Malignant neoplasm of brain, unspecified
C720Malignant neoplasm of spinal cord
C721Malignant neoplasm of cauda equina
C7220Malignant neoplasm of unspecified olfactory nerve
C7221Malignant neoplasm of right olfactory nerve
C7222Malignant neoplasm of left olfactory nerve
C7230Malignant neoplasm of unspecified optic nerve
C7231Malignant neoplasm of right optic nerve
C7232Malignant neoplasm of left optic nerve
C7240Malignant neoplasm of unspecified acoustic nerve
C7241Malignant neoplasm of right acoustic nerve
C7242Malignant neoplasm of left acoustic nerve
C7250Malignant neoplasm of unspecified cranial nerve
C7259Malignant neoplasm of other cranial nerves
C729Malignant neoplasm of central nervous system, unspecified
C751Malignant neoplasm of pituitary gland
C752Malignant neoplasm of craniopharyngeal duct
C753Malignant neoplasm of pineal gland
C773Secondary and unspecified malignant neoplasm of axilla and upper limb lymph nodes
C8310Mantle cell lymphoma, unspecified site
C8311Mantle cell lymphoma, lymph nodes of head, face, and neck
C8312Mantle cell lymphoma, intrathoracic lymph nodes
C8313Mantle cell lymphoma, intra-abdominal lymph nodes
C8314Mantle cell lymphoma, lymph nodes of axilla and upper limb
C8315Mantle cell lymphoma, lymph nodes of inguinal region and lower limb
C8316Mantle cell lymphoma, intrapelvic lymph nodes
C8317Mantle cell lymphoma, spleen
C8318Mantle cell lymphoma, lymph nodes of multiple sites
C8319Mantle cell lymphoma, extranodal and solid organ sites
C831AMantle cell lymphoma, in remission
C8330Diffuse large B-cell lymphoma, unspecified site
C8331Diffuse large B-cell lymphoma, lymph nodes of head, face, and neck
C8332Diffuse large B-cell lymphoma, intrathoracic lymph nodes
C8333Diffuse large B-cell lymphoma, intra-abdominal lymph nodes
C8334Diffuse large B-cell lymphoma, lymph nodes of axilla and upper limb
C8335Diffuse large B-cell lymphoma, lymph nodes of inguinal region and lower limb
C8336Diffuse large B-cell lymphoma, intrapelvic lymph nodes
C8337Diffuse large B-cell lymphoma, spleen
C8338Diffuse large B-cell lymphoma, lymph nodes of multiple sites
C83390Primary central nervous system lymphoma
C83398Diffuse large B-cell lymphoma of other extranodal and solid organ sites
C833ADiffuse large B-cell lymphoma, in remission
C8350Lymphoblastic (diffuse) lymphoma, unspecified site
C8351Lymphoblastic (diffuse) lymphoma, lymph nodes of head, face, and neck
C8352Lymphoblastic (diffuse) lymphoma, intrathoracic lymph nodes
C8353Lymphoblastic (diffuse) lymphoma, intra-abdominal lymph nodes
C8354Lymphoblastic (diffuse) lymphoma, lymph nodes of axilla and upper limb
C8355Lymphoblastic (diffuse) lymphoma, lymph nodes of inguinal region and lower limb
C8356Lymphoblastic (diffuse) lymphoma, intrapelvic lymph nodes
C8357Lymphoblastic (diffuse) lymphoma, spleen
C8358Lymphoblastic (diffuse) lymphoma, lymph nodes of multiple sites
C8359Lymphoblastic (diffuse) lymphoma, extranodal and solid organ sites
C835ALymphoblastic (diffuse) lymphoma, in remission
C8370Burkitt lymphoma, unspecified site
C8371Burkitt lymphoma, lymph nodes of head, face, and neck
C8372Burkitt lymphoma, intrathoracic lymph nodes
C8373Burkitt lymphoma, intra-abdominal lymph nodes
C8374Burkitt lymphoma, lymph nodes of axilla and upper limb
C8375Burkitt lymphoma, lymph nodes of inguinal region and lower limb
C8376Burkitt lymphoma, intrapelvic lymph nodes
C8377Burkitt lymphoma, spleen
C8378Burkitt lymphoma, lymph nodes of multiple sites
C8379Burkitt lymphoma, extranodal and solid organ sites
C837ABurkitt lymphoma, in remission
C8400Mycosis fungoides, unspecified site
C8401Mycosis fungoides, lymph nodes of head, face, and neck
C8402Mycosis fungoides, intrathoracic lymph nodes
C8403Mycosis fungoides, intra-abdominal lymph nodes
C8404Mycosis fungoides, lymph nodes of axilla and upper limb
C8405Mycosis fungoides, lymph nodes of inguinal region and lower limb
C8406Mycosis fungoides, intrapelvic lymph nodes
C8407Mycosis fungoides, spleen
C8408Mycosis fungoides, lymph nodes of multiple sites
C8409Mycosis fungoides, extranodal and solid organ sites
C840AMycosis fungoides, in remission
C8460Anaplastic large cell lymphoma, ALK-positive, unspecified site
C8461Anaplastic large cell lymphoma, ALK-positive, lymph nodes of head, face, and neck
C8462Anaplastic large cell lymphoma, ALK-positive, intrathoracic lymph nodes
C8463Anaplastic large cell lymphoma, ALK-positive, intra-abdominal lymph nodes
C8464Anaplastic large cell lymphoma, ALK-positive, lymph nodes of axilla and upper limb
C8465Anaplastic large cell lymphoma, ALK-positive, lymph nodes of inguinal region and lower limb
C8466Anaplastic large cell lymphoma, ALK-positive, intrapelvic lymph nodes
C8467Anaplastic large cell lymphoma, ALK-positive, spleen
C8468Anaplastic large cell lymphoma, ALK-positive, lymph nodes of multiple sites
C8469Anaplastic large cell lymphoma, ALK-positive, extranodal and solid organ sites
C846AAnaplastic large cell lymphoma, ALK-positive, in remission
C8490Mature T/NK-cell lymphomas, unspecified, unspecified site
C8491Mature T/NK-cell lymphomas, unspecified, lymph nodes of head, face, and neck
C8492Mature T/NK-cell lymphomas, unspecified, intrathoracic lymph nodes
C8493Mature T/NK-cell lymphomas, unspecified, intra-abdominal lymph nodes
C8494Mature T/NK-cell lymphomas, unspecified, lymph nodes of axilla and upper limb
C8495Mature T/NK-cell lymphomas, unspecified, lymph nodes of inguinal region and lower limb
C8496Mature T/NK-cell lymphomas, unspecified, intrapelvic lymph nodes
C8497Mature T/NK-cell lymphomas, unspecified, spleen
C8498Mature T/NK-cell lymphomas, unspecified, lymph nodes of multiple sites
C8499Mature T/NK-cell lymphomas, unspecified, extranodal and solid organ sites
C849AMature T/NK-cell lymphomas, unspecified, in remission
C84A0Cutaneous T-cell lymphoma, unspecified, unspecified site
C84A1Cutaneous T-cell lymphoma, unspecified lymph nodes of head, face, and neck
C84A2Cutaneous T-cell lymphoma, unspecified, intrathoracic lymph nodes
C84A3Cutaneous T-cell lymphoma, unspecified, intra-abdominal lymph nodes
C84A4Cutaneous T-cell lymphoma, unspecified, lymph nodes of axilla and upper limb
C84A5Cutaneous T-cell lymphoma, unspecified, lymph nodes of inguinal region and lower limb
C84A6Cutaneous T-cell lymphoma, unspecified, intrapelvic lymph nodes
C84A7Cutaneous T-cell lymphoma, unspecified, spleen
C84A8Cutaneous T-cell lymphoma, unspecified, lymph nodes of multiple sites
C84A9Cutaneous T-cell lymphoma, unspecified, extranodal and solid organ sites
C84AACutaneous T-cell lymphoma, unspecified, in remission
C84Z0Other mature T/NK-cell lymphomas, unspecified site
C84Z1Other mature T/NK-cell lymphomas, lymph nodes of head, face, and neck
C84Z2Other mature T/NK-cell lymphomas, intrathoracic lymph nodes
C84Z3Other mature T/NK-cell lymphomas, intra-abdominal lymph nodes
C84Z4Other mature T/NK-cell lymphomas, lymph nodes of axilla and upper limb
C84Z5Other mature T/NK-cell lymphomas, lymph nodes of inguinal region and lower limb
C84Z6Other mature T/NK-cell lymphomas, intrapelvic lymph nodes
C84Z7Other mature T/NK-cell lymphomas, spleen
C84Z8Other mature T/NK-cell lymphomas, lymph nodes of multiple sites
C84Z9Other mature T/NK-cell lymphomas, extranodal and solid organ sites
C84ZAOther mature T/NK-cell lymphomas, in remission
C8600Extranodal NK/T-cell lymphoma, nasal type not having achieved remission
C8601Extranodal NK/T-cell lymphoma, nasal type, in remission
C8610Hepatosplenic T-cell lymphoma not having achieved remission
C8611Hepatosplenic T-cell lymphoma, in remission
C8620Enteropathy-type (intestinal) T-cell lymphoma not having achieved remission
C8621Enteropathy-type (intestinal) T-cell lymphoma, in remission
C8660Primary cutaneous CD30-positive T-cell proliferations not having achieved remission
C8661Primary cutaneous CD30-positive T-cell proliferations, in remission
C91A0Mature B-cell leukemia Burkitt-type not having achieved remission
C91A1Mature B-cell leukemia Burkitt-type, in remission
C91A2Mature B-cell leukemia Burkitt-type, in relapse
C9220Atypical chronic myeloid leukemia, BCR/ABL-negative, not having achieved remission
C9221Atypical chronic myeloid leukemia, BCR/ABL-negative, in remission
C9222Atypical chronic myeloid leukemia, BCR/ABL-negative, in relapse
C9290Myeloid leukemia, unspecified, not having achieved remission
C9291Myeloid leukemia, unspecified in remission
C9292Myeloid leukemia, unspecified in relapse
C92Z0Other myeloid leukemia not having achieved remission
C92Z1Other myeloid leukemia, in remission
C92Z2Other myeloid leukemia, in relapse
C9310Chronic myelomonocytic leukemia not having achieved remission
C9311Chronic myelomonocytic leukemia, in remission
C9312Chronic myelomonocytic leukemia, in relapse
C9330Juvenile myelomonocytic leukemia, not having achieved remission
C9331Juvenile myelomonocytic leukemia, in remission
C9332Juvenile myelomonocytic leukemia, in relapse
C9390Monocytic leukemia, unspecified, not having achieved remission
C9391Monocytic leukemia, unspecified in remission
C9392Monocytic leukemia, unspecified in relapse
C93Z0Other monocytic leukemia, not having achieved remission
C93Z1Other monocytic leukemia, in remission
C93Z2Other monocytic leukemia, in relapse
C9430Mast cell leukemia not having achieved remission
C9431Mast cell leukemia, in remission
C9432Mast cell leukemia, in relapse
C9480Other specified leukemias not having achieved remission
C9481Other specified leukemias, in remission
C9482Other specified leukemias, in relapse

Where these codes sat in the V22 model

The V28 recalibration renumbered and regrouped categories; this table shows which legacy V22 categories the same ICD-10 codes belonged to, which is the quickest way to reconcile a V22-era HCC gap list with the current model.

V22 categories that the HCC 20 codes mapped to
V22 HCCCodes
10142
990
111

Capturing and defending the category

A category counts for a payment year when a mapped diagnosis is documented at least once during the data collection year by an acceptable provider type at a face-to-face or audio-video encounter, and when the note shows the condition was monitored, evaluated, assessed or treated. Chronic conditions do not carry forward: a category that is not re-documented in the year drops out of the score, which is why annual wellness visits and problem-list reconciliation are where most recapture happens. Risk adjustment data validation audits sample enrollees and ask for the medical record behind each submitted category; an unsupported category is removed and, under the extrapolation rules, the error rate is applied across the contract. The QuickIntell risk adjustment product surfaces suspected and unsupported categories from the chart, and the HCC hub lists every V28 category with its factor and code count.

Frequently asked questions

Which ICD-10 codes map to HCC 20?

233 ICD-10-CM codes map to HCC 20 in the CMS PY2027 initial mapping, for example C153 Malignant neoplasm of upper third of esophagus; C154 Malignant neoplasm of middle third of esophagus; C155 Malignant neoplasm of lower third of esophagus; C158 Malignant neoplasm of overlapping sites of esophagus. The full list is on this page; a code counts only when it is documented at a face-to-face or video encounter in the data collection year and supported by the record.

How much does HCC 20 add to a risk score?

The V28 relative factor for HCC 20 is 1.136 for a community, non-dual, aged beneficiary, 1.166 for full-benefit dual aged, 0.978 for non-dual disabled and 0.672 for long-term institutional members. A factor of 1.000 equals the expected annual cost of an average beneficiary, so the category's share of the payment follows the plan's base rate for that segment.

Does HCC 20 count together with related categories?

No. Within a hierarchy only the most severe category is paid. HCC 20 is dropped when HCC 17 (Cancer Metastatic to Lung, Liver, Brain, and Other Organs; Acute Myeloid Leukemia Except Promyelocytic) or HCC 18 (Cancer Metastatic to Bone, Other and Unspecified Metastatic Cancer; Acute Leukemia Except Myeloid) or HCC 19 (Myelodysplastic Syndromes, Multiple Myeloma, and Other Cancers) is also present, and it drops HCC 21, HCC 22, HCC 23 when it is present.

What has to be documented for HCC 20 to be valid?

The diagnosis must be recorded by an acceptable provider type during a face-to-face or audio-video encounter in the service year, with the note showing that the condition was monitored, evaluated, assessed or treated. Risk adjustment data validation audits recover payment for categories the record does not support, so the code on the claim and the assessment in the note must match.

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-10-02. Verify against the primary file before billing or contracting decisions.

Disclaimer

Relative factors and mappings are reproduced from the CMS risk adjustment model files as an operational reference. Payment depends on the plan's base rate, normalization, the coding intensity adjustment and the enrollee's segment. Not legal, clinical or billing advice.